NetTargets Inc. is selected for the Korea AI Startup 100

NetTargets Inc. was selected for the ‘Korea AI Startup 100’, a project to discover next-generation unicorn companies in the field of artificial intelligence (AI). The project is led by The Korea Economic Daily and KT AI One Team.

NetTargets and Cellkey sign MoU to collaborate on biomarker discovery

NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.

09 Jun 2021

NetTargets will present at KASBP's eSymposium on June 4.

Jaehong Shin, CDO of NetTargets will present at Korean American Society in Biotech and Pharmaceuticals (KASBP) eSymposium on June 4, 2021 about computational approaches for early phase drug discovery research in the age of AI.

01 Apr 2021

NetTargets Inc. is selected as one of 25 notable AI startups in 2021 by AI Times.

AI Times recognized NetTargets as one of the notable AI startups in biopharmaceuticals in 2021.

05 Jan 2021

Comming soon

Our next news and events are coming soon

BACK TO THE LIST